the US FDA EAU as a point-of-care diagnostic in the medical environment. According to the company, Palogen, Inc. is also working to have their high-innovation single-use test chip and scanner approved for over-the-counter and prescription home usage. The technology that powers the New Ion’s fingernail-sized nano electronic chip is made with millions of tiny holes called nanopores that run through the silicon chip’s surface. These nanopores substantially increase the detecting surface, allowing for the sensitive and immediate recognition of viral RNA’s electrical charge.
The elimination of the DNA or RNA amplification reaction, which is a critical process in RT-PCR and LAMP-based assays, reduces detection time from 15 to 30 minutes to 3 minutes, including sample, processing, and findings. The signal generated by viral genetic pieces is detected using a small, inexpensive USB-powered scanner. Multiple genes may be assessed concurrently using this technology, and research is ongoing to create tests for cancer, influenza, HIV, and Lyme disease, and others.
Palogen CEO Kyung Joon Han spoke about the New Ion test technology. He said, “New Ion is an…